{"id":"NCT00828295","sponsor":"Helsinn Healthcare SA","briefTitle":"Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients","officialTitle":"A Multicenter, Double-blind, Randomized, Parallel Group, Stratified Study to Assess the Safety and Efficacy of Single IV Doses of Palonosetron to Prevent Postoperative Nausea and Vomiting in Pediatric Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2008-12","completion":"2009-01","firstPosted":"2009-01-23","resultsPosted":"2014-08-15","lastUpdate":"2015-04-03"},"enrollment":150,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Postoperative Nausea and Vomiting"],"interventions":[{"type":"DRUG","name":"palonosetron","otherNames":[]},{"type":"DRUG","name":"palonosetron","otherNames":[]}],"arms":[{"label":"1 mcg/kg arm","type":"EXPERIMENTAL"},{"label":"3 mcg/kg arm","type":"EXPERIMENTAL"}],"summary":"The objective of the study is to assess the safety and efficacy of two doses of IV palonosetron each administered as a single dose for the prevention of postoperative nausea and vomiting through 72 hours postoperatively in children aged 28 days up to 16 years inclusive undergoing surgical procedures requiring general endotracheal inhalation anesthesia.","primaryOutcome":{"measure":"Proportion of Patients With no Emetic Episodes in the Overall Time Period 0-72 Hours Post-operatively","timeFrame":"0-72 hours post-operatively","effectByArm":[{"arm":"1 mcg/kg Arm","deltaMin":88,"sd":null},{"arm":"3 mcg/kg Arm","deltaMin":84,"sd":null}],"pValues":[]},"eligibility":{"minAge":"28 Days","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":13,"countries":["Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":74},"commonTop":["Procedural pain","Oropharyngeal pain","Vomiting","Rhinalgia","Asthenia"]}}